On Tuesday, February 28th, Dr. Arun Jesudian of NewYork-Presbyterian Hospital/Weill Cornell presented: “Post-SVR Care”
This webinar was sponsored by the Empire Liver Foundation, an organization dedicated to increasing community awareness of liver disease and providing education on liver disease to health care providers and patients. If you would like to receive continuing education (CE) for this webinar, click here. If you have any questions about receiving continuing education, please contact email@example.com
1. Recognize the importance of fibrosis staging prior to Hepatitis C therapy
2. Identify who needs lifelong screening for hepatocellular carcinoma after Hepatitis C care
3. Learn how to evaluate elevated liver tests following Hepatitis C care
Dr. Arun Jesudian is a Transplant Hepatologist in the Center for Liver Disease and Transplantation of NewYork-Presbyterian Hospital/Weill Cornell Medicine. He earned his BA from the University of Virginia where he was an Echols scholar and his MD from Virginia Commonwealth University School of Medicine where he was elected to the Alpha Omega Alpha Medical Honor Society. He then completed residency in Internal Medicine and fellowship in Gastroenterology at NewYork-Presbyterian Hospital/Weill Cornell Medical College as well as advanced fellowship training in Transplant Hepatology at NewYork-Presbyterian Hospital/Columbia University. Dr. Jesudian is the Director of Inpatient Liver Services at NYPH/Weill Cornell and also serves as a member of the Department of Medicine Quality Improvement Patient Safety Committee. His clinical research focuses on the areas of quality improvement in cirrhosis management and complications of portal hypertension.